NoviPel

📍 Copenhagen, Denmark🗓 Founded 2014👥 5 employees💰 Last funded Dec 2018
Medical Equipment Manufacturing🌐 novipel.com
Website LinkedIn
NoviPel is a Danish medtech company of healthcare professionals, designers, and engineers disrupting the market for female urinary incontinence (UI) with our biofeedback device; VisU Pro. VisU Pro is a revolutionising biofeedback solution for clinical assessment and diagnosis of female urinary incontinence (UI) supporting the first line treatment: pelvic floor muscle training (PFMT) NoviPel was founded in 2014 by two siblings; MD Louise Hennings specialising in gynecology and Industrial Designer Alexander Hennings. We are more than just our device. VisU Pro is an end to a bigger mean; creating a platform of research based knowledge on how to improve treatment of incontinence through pelvic floor muscle training (PFMT). We want to inform women about urinary incontinence and help break the taboo so we can raise the current numbers of women seeking professional help, and making the number of women with urinary incontinence shrink profoundly. We encourage women suffering from involuntary leakage of urine, no matter the severity of it, to take control and seek medical advice.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in NoviPel?
NoviPel has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did NoviPel last raise funding?
The most recent investment in NoviPel recorded on gritt.io was in December 2018.
When was NoviPel founded?
NoviPel was founded in 2014.
What industry is NoviPel in?
NoviPel operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is NoviPel based?
NoviPel is headquartered in Copenhagen, Denmark.